Reply to "Pityriasis rosea during COVID-19 and its pathogenesis".
作者信息
Nussbaum Dillon, Wei Chapman, Pakhchanian Haig, Raiker Rahul, Liu Ivan Z, Friedman Adam
机构信息
Department of Dermatology, George Washington University, Washington, District of Columbia.
Department of Medicine, Staten Island University Hospital, Staten Island, New York.
出版信息
JAAD Int. 2022 Dec;9:153-154. doi: 10.1016/j.jdin.2022.05.014. Epub 2022 Sep 27.
Abstract
摘要
相似文献
1
Reply to "Pityriasis rosea during COVID-19 and its pathogenesis".对“新型冠状病毒肺炎期间的玫瑰糠疹及其发病机制”的回复
JAAD Int. 2022 Dec;9:153-154. doi: 10.1016/j.jdin.2022.05.014. Epub 2022 Sep 27.
2
Reduction in new pityriasis rosea diagnoses during the COVID-19 pandemic: Evidence in support of a viral etiology.新型冠状病毒肺炎大流行期间玫瑰糠疹新诊断病例数的减少：支持病毒病因学的证据
JAAD Int. 2022 Jun;7:124-125. doi: 10.1016/j.jdin.2022.03.005. Epub 2022 Mar 17.
3
Pityriasis Rosea Induced by COVID-19 Vaccination.新冠疫苗接种诱发的玫瑰糠疹
Eur J Case Rep Intern Med. 2022 Feb 3;9(2):003164. doi: 10.12890/2022_003164. eCollection 2022.
4
The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.HHV-6 感染在 COVID-19 大流行中的临床特征：玫瑰糠疹和川崎病。
Dermatol Ther. 2020 Jul;33(4):e13730. doi: 10.1111/dth.13730. Epub 2020 Jun 29.
5
Study of role of streptococcal throat infection in pityriasis rosea.链球菌性咽喉感染在玫瑰糠疹中作用的研究。
Indian J Dermatol. 2008;53(4):171-3. doi: 10.4103/0019-5154.44787.
6
Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.新型冠状病毒病信使核糖核酸疫苗接种后出现玫瑰糠疹样皮疹：一例病例报告及文献复习
JAAD Int. 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Epub 2022 Feb 9.
7
A Case-Control Study on the Take-Off Sign in Lesional Skin Biopsies of Patients with Pityriasis Rosea.玫瑰糠疹患者皮损皮肤活检中“起飞征”的病例对照研究
Iran J Pathol. 2016 Fall;11(4):416-417.
8
Pityriasis rosea during COVID-19 and its pathogenesis.新型冠状病毒肺炎期间的玫瑰糠疹及其发病机制。
JAAD Int. 2022 Dec;9:159-160. doi: 10.1016/j.jdin.2022.05.015. Epub 2022 Sep 22.
9
Pityriasis rosea: roles of the dermatology nurse.
Dermatol Nurs. 2004 Apr;16(2):130-4; quiz 137.
10
Pityriasis rosea.玫瑰糠疹
Am Fam Physician. 2004 Jan 1;69(1):87-91.
本文引用的文献
1
Reduction in new pityriasis rosea diagnoses during the COVID-19 pandemic: Evidence in support of a viral etiology.新型冠状病毒肺炎大流行期间玫瑰糠疹新诊断病例数的减少：支持病毒病因学的证据
JAAD Int. 2022 Jun;7:124-125. doi: 10.1016/j.jdin.2022.03.005. Epub 2022 Mar 17.
2
The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.HHV-6 感染在 COVID-19 大流行中的临床特征：玫瑰糠疹和川崎病。
Dermatol Ther. 2020 Jul;33(4):e13730. doi: 10.1111/dth.13730. Epub 2020 Jun 29.
3
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.COVID-19 皮肤表现分类：西班牙 375 例快速前瞻性全国共识研究。
Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10.
4
Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7.玫瑰糠疹与人类疱疹病毒6型和7型再激活相关的更多证据。
J Invest Dermatol. 2005 Jun;124(6):1234-40. doi: 10.1111/j.0022-202X.2005.23719.x.
5
Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6.玫瑰糠疹与人类疱疹病毒7型和人类疱疹病毒6型的全身性活动性感染有关。
J Invest Dermatol. 2002 Oct;119(4):793-7. doi: 10.1046/j.1523-1747.2002.00200.x.
Zotero 插件